{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T01:13:16Z","timestamp":1792285996334,"version":"4.4.0"},"reference-count":65,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T00:00:00Z","timestamp":1536796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Given the safety and potential benefits of intravenous ascorbic acid (AA) administration in cancer patients, there is merit in further exploring this therapeutic concept. In this review, we discuss the potential benefits of intravenous AA administration on colorectal cancer and we specifically focus on its effect on glycolysis in mutant and wild type RAS. We perform a PubMed and Ovid MEDLINE search using ascorbic acid, intravenous vitamin C, KRAS mutation, BRAF mutation and colorectal cancer (CRC) as keywords. At the cellular level, colorectal cancer cells undergo a metabolic shift called the Warburg effect to allow for more glucose absorption and utilization of glycolysis. This shift also allows AA to enter which leads to a disruption in the Warburg effect and a shutdown of the downstream KRAS pathway in mutated KRAS colon cancer cells. At the clinical level, AA is associated with tumour regression in advanced disease and improved tolerability and side effects of standard therapy. Based on these findings, we conclude that further clinical trials are needed on a larger scale to examine the therapeutic benefits of AA in colon cancer.<\/jats:p>","DOI":"10.3390\/ijms19092752","type":"journal-article","created":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T11:46:04Z","timestamp":1536839164000},"page":"2752","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Ascorbic Acid in Colon Cancer: From the Basic to the Clinical Applications"],"prefix":"10.3390","volume":"19","author":[{"given":"Ibrahim","family":"El Halabi","sequence":"first","affiliation":[{"name":"Department of Internal Medicine\u2014Division of Hematology-Oncology, American University of Beirut Medical Center, Riad El Solh, Beirut 1107 2020, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle","family":"Bejjany","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine\u2014Division of Hematology-Oncology, American University of Beirut Medical Center, Riad El Solh, Beirut 1107 2020, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rihab","family":"Nasr","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Cell Biology and Physiology, American University of Beirut, Beirut 1107 2020, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Mukherji","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine\u2014Division of Hematology-Oncology, American University of Beirut Medical Center, Riad El Solh, Beirut 1107 2020, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Temraz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine\u2014Division of Hematology-Oncology, American University of Beirut Medical Center, Riad El Solh, Beirut 1107 2020, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4092-2531","authenticated-orcid":false,"given":"Farah J.","family":"Nassar","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine\u2014Division of Hematology-Oncology, American University of Beirut Medical Center, Riad El Solh, Beirut 1107 2020, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidar","family":"El Darsa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine\u2014Division of Hematology-Oncology, American University of Beirut Medical Center, Riad El Solh, Beirut 1107 2020, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Shamseddine","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine\u2014Division of Hematology-Oncology, American University of Beirut Medical Center, Riad El Solh, Beirut 1107 2020, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,9,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: Sources, methods and major patterns in globocan 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.clcc.2017.06.007","article-title":"Clinical usefulness of tools to support decision-making for palliative treatment of metastatic colorectal cancer: A systematic review","volume":"17","author":"Engelhardt","year":"2017","journal-title":"Clin. Colorectal Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nrc1503","article-title":"Targeting the mitogen-activated protein kinase cascade to treat cancer","volume":"4","author":"Herrera","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.mam.2012.12.002","article-title":"The sodium-dependent ascorbic acid transporter family slc23","volume":"34","author":"Suzuki","year":"2013","journal-title":"Mol. Asp. Med."},{"key":"ref_5","first-page":"5171","article-title":"Kras mutation testing in metastatic colorectal cancer","volume":"18","author":"Tan","year":"2012","journal-title":"World J. Gastroenterol. WJG"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1158\/0008-5472.CAN-06-0191","article-title":"Kras mutation status is predictive of response to cetuximab therapy in colorectal cancer","volume":"66","author":"Lievre","year":"2006","journal-title":"Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/1534735414534463","article-title":"Intravenous vitamin C and cancer: A systematic review","volume":"13","author":"Fritz","year":"2014","journal-title":"Integr. Cancer Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"25372","DOI":"10.18632\/oncotarget.15913","article-title":"Interleukin-22 promotes aerobic glycolysis associated with tumor progression via targeting hexokinase-2 in human colon cancer cells","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3892\/br.2016.719","article-title":"Advances in glucose metabolism research in colorectal cancer","volume":"5","author":"Fang","year":"2016","journal-title":"Biomed. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.15252\/embj.201488598","article-title":"Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer","volume":"33","author":"Pate","year":"2014","journal-title":"EMBO J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1126\/science.1174229","article-title":"Glucose deprivation contributes to the development of kras pathway mutations in tumor cells","volume":"325","author":"Yun","year":"2009","journal-title":"Science"},{"key":"ref_13","first-page":"7","article-title":"Pharmacokinetics of vitamin C: Insights into the oral and intravenous administration of ascorbate","volume":"27","author":"Duconge","year":"2008","journal-title":"P. R. Health Sci. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1479-5876-11-191","article-title":"Clinical experience with intravenous administration of ascorbic acid: Achievable levels in blood for different states of inflammation and disease in cancer patients","volume":"11","author":"Mikirova","year":"2013","journal-title":"J. Transl. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/0003-4819-140-7-200404060-00010","article-title":"Vitamin c pharmacokinetics: Implications for oral and intravenous use","volume":"140","author":"Padayatty","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJM197909273011303","article-title":"Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer: A controlled trial","volume":"301","author":"Creagan","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"13604","DOI":"10.1073\/pnas.0506390102","article-title":"Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues","volume":"102","author":"Chen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1503\/cmaj.050346","article-title":"Intravenously administered vitamin C as cancer therapy: Three cases","volume":"174","author":"Padayatty","year":"2006","journal-title":"Can. Med.Assoc. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/07315724.2003.10719284","article-title":"The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer","volume":"22","author":"Drisko","year":"2003","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.redox.2017.08.017","article-title":"Augmentation of intracellular iron using iron sucrose enhances the toxicity of pharmacological ascorbate in colon cancer cells","volume":"14","author":"Brandt","year":"2018","journal-title":"Redox Biol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Miura, K., Haraguchi, M., Ito, H., and Tai, A. (2018). Potential antitumor activity of 2-O-alpha-d-glucopyranosyl-6-O-(2-pentylheptanoyl)-l-ascorbic acid. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19020535"},{"key":"ref_22","first-page":"353","article-title":"New insights into the physiology and pharmacology of vitamin C","volume":"164","author":"Padayatty","year":"2001","journal-title":"Can. Med. Assoc. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"532","DOI":"10.2307\/3579271","article-title":"Catalytic metals, ascorbate and free radicals: Combinations to avoid","volume":"145","author":"Buettner","year":"1996","journal-title":"Radiat. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1158\/1078-0432.CCR-09-1713","article-title":"Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer","volume":"16","author":"Du","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1080\/01635581.2011.605984","article-title":"Pharmacologic doses of ascorbic acid repress specificity protein (sp) transcription factors and sp-regulated genes in colon cancer cells","volume":"63","author":"Pathi","year":"2011","journal-title":"Nutr. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4110\/in.2012.12.5.189","article-title":"Vitamin c induces apoptosis in human colon cancer cell line, hct-8 via the modulation of calcium influx in endoplasmic reticulum and the dissociation of bad from 14-3-3beta","volume":"12","author":"Kim","year":"2012","journal-title":"Immune Netw."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.freeradbiomed.2014.01.033","article-title":"Intracellular ascorbate enhances hypoxia-inducible factor (hif)-hydroxylase activity and preferentially suppresses the hif-1 transcriptional response","volume":"69","author":"Kuiper","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"13896","DOI":"10.1038\/srep13896","article-title":"Metabolomic alterations in human cancer cells by vitamin C-induced oxidative stress","volume":"5","author":"Uetaki","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejcb.2016.04.001","article-title":"Ascorbic acid and colon cancer: An oxidative stimulus to cell death depending on cell profile","volume":"95","author":"Pires","year":"2016","journal-title":"Eur. J. Cell Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bbcan.2012.12.004","article-title":"Expression of glucose transporters in cancers","volume":"1835","author":"Szablewski","year":"2013","journal-title":"Biochim. Biophys. Acta (BBA) Rev. Cancer"},{"key":"ref_31","first-page":"96","article-title":"The mapk (erk) pathway: Investigational combinations for the treatment of braf-mutated metastatic melanoma","volume":"38","author":"McCain","year":"2013","journal-title":"Pharm. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1074\/mcp.M116.058925","article-title":"Oncogenic kras and braf drive metabolic reprogramming in colorectal cancer","volume":"15","author":"Hutton","year":"2016","journal-title":"Mol. Cell. Proteom."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"47954","DOI":"10.18632\/oncotarget.10087","article-title":"Vitamin c uncouples the warburg metabolic switch in kras mutant colon cancer","volume":"7","author":"Aguilera","year":"2016","journal-title":"Oncotarget"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1126\/science.aaa5004","article-title":"Vitamin c selectively kills kras and braf mutant colorectal cancer cells by targeting gapdh","volume":"350","author":"Yun","year":"2015","journal-title":"Science"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.freeradbiomed.2016.03.009","article-title":"L-ascorbic acid can abrogate svct-2-dependent cetuximab resistance mediated by mutant kras in human colon cancer cells","volume":"95","author":"Jung","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1073\/pnas.73.10.3685","article-title":"Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer","volume":"73","author":"Cameron","year":"1976","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJM198501173120301","article-title":"High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy: A randomized double-blind comparison","volume":"312","author":"Moertel","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1634\/theoncologist.9-1-80","article-title":"Complementary and alternative therapies for cancer","volume":"9","author":"Cassileth","year":"2004","journal-title":"Oncologist"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Monti, D.A., Mitchell, E., Bazzan, A.J., Littman, S., Zabrecky, G., Yeo, C.J., Pillai, M.V., Newberg, A.B., Deshmukh, S., and Levine, M. (2012). Phase i evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0029794"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Padayatty, S.J., Sun, A.Y., Chen, Q., Espey, M.G., Drisko, J., and Levine, M. (2010). Vitamin c: Intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0011414"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"222ra218","DOI":"10.1126\/scitranslmed.3007154","article-title":"High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy","volume":"6","author":"Ma","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3346\/jkms.2007.22.1.7","article-title":"Changes of terminal cancer patients\u2019 health-related quality of life after high dose vitamin C administration","volume":"22","author":"Yeom","year":"2007","journal-title":"J. Korean Med. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pmu.2012.05.008","article-title":"High-dose intravenous vitamin C improves quality of life in cancer patients","volume":"1","author":"Takahashi","year":"2012","journal-title":"Person. Med. Univ."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3389\/fonc.2014.00283","article-title":"The effect of intravenous vitamin C on cancer-and chemotherapy-related fatigue and quality of life","volume":"4","author":"Carr","year":"2014","journal-title":"Front. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.2147\/CMAR.S161824","article-title":"Evidence-based complementary treatment of pancreatic cancer: A review of adjunct therapies including paricalcitol, hydroxychloroquine, intravenous vitamin C, statins, metformin, curcumin, and aspirin","volume":"10","author":"Bigelsen","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3747\/co.25.3790","article-title":"Intravenous vitamin C in the supportive care of cancer patients: A review and rational approach","volume":"25","author":"Klimant","year":"2018","journal-title":"Curr. Oncol."},{"key":"ref_47","first-page":"87","article-title":"High dose intravenous vitamin C and long time survival of a patient with cancer of the head of the pancreas","volume":"10","author":"Jackson","year":"1995","journal-title":"J. Orthomol. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1159\/000226988","article-title":"Reticulum cell sarcoma: Two complete \u2018spontaneous\u2019 regressions, in reponse to high-dose ascorbic acid therapy","volume":"48","author":"Campbell","year":"1991","journal-title":"Oncology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0009-2797(75)90007-1","article-title":"The orthomolecular treatment of cancer: III. Reticulum cell sarcoma: Double complete regression induced by high-dose ascorbic acid therapy","volume":"11","author":"Cameron","year":"1975","journal-title":"Chem. Biol. Interact."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1385\/MO:23:2:263","article-title":"Efficacy and safety results with the combination therapy of arsenic trioxide, dexamethasone, and ascorbic acid in multiple myeloma patients","volume":"23","author":"Reed","year":"2006","journal-title":"Med. Oncol."},{"key":"ref_51","first-page":"983","article-title":"Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-\/radiotherapy and aftercare: Results of a retrospective, multicentre, epidemiological cohort study in germany","volume":"25","author":"Vollbracht","year":"2011","journal-title":"In Vivo"},{"key":"ref_52","first-page":"103","article-title":"Prolongation of survival times of terminal cancer patients by administration of large doses of ascorbate","volume":"23","author":"Murata","year":"1982","journal-title":"Int. J. Vitam. Nutr. Res. Suppl."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1158\/0008-5472.CAN-10-0263","article-title":"Low ascorbate levels are associated with increased hypoxia-inducible factor-1 activity and an aggressive tumor phenotype in endometrial cancer","volume":"70","author":"Kuiper","year":"2010","journal-title":"Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1191\/0269216305pm970oa","article-title":"Vitamin c deficiency in cancer patients","volume":"19","author":"Mayland","year":"2005","journal-title":"Palliat. Med."},{"key":"ref_55","first-page":"249","article-title":"Pharmacological ascorbic acid suppresses syngeneic tumor growth and metastases in hormone-refractory prostate cancer","volume":"24","author":"Pollard","year":"2010","journal-title":"In Vivo"},{"key":"ref_56","unstructured":"Riordan, H.D., Riordan, N.H., Jackson, J.A., Casciari, J.J., Hunninghake, R., Gonz\u00e1lez, M.J., Mora, E.M., Miranda-Massari, J.R., Rosario, N., and Rivera, A. (2004). Intravenous vitamin C as a chemotherapy agent: A report on clinical cases. P. R. Health Sci. J., 23."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1479-5876-9-25","article-title":"Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?","volume":"9","author":"Ichim","year":"2011","journal-title":"J. Transl. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/CAD.0000000000000603","article-title":"Treatment of pancreatic cancer with intravenous vitamin C: A case report","volume":"29","author":"Drisko","year":"2018","journal-title":"Anti-Cancer Drugs"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00280-013-2070-8","article-title":"Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (pacman): Results from a phase i clinical trial","volume":"71","author":"Welsh","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Hoffer, L.J., Robitaille, L., Zakarian, R., Melnychuk, D., Kavan, P., Agulnik, J., Cohen, V., Small, D., and Miller, W.H. (2015). High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: A phase i-ii clinical trial. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0120228"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/1479-5876-10-189","article-title":"Effect of high-dose intravenous vitamin C on inflammation in cancer patients","volume":"10","author":"Mikirova","year":"2012","journal-title":"J. Transl. Med."},{"key":"ref_62","first-page":"269","article-title":"A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients","volume":"24","author":"Riordan","year":"2009","journal-title":"P. R. Health Sci. J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1200\/jco.2012.30.4_suppl.323","article-title":"A phase i open-label, dose-escalation study of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer","volume":"30","author":"Littman","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_64","first-page":"325","article-title":"Levels of plasma vitamin e, vitamin C, tbars, and cholesterol in male patients with colorectal tumors","volume":"68","author":"Saygili","year":"2003","journal-title":"Biochemistry"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"9147279","DOI":"10.1155\/2016\/9147279","article-title":"Effect of intravenous high dose vitamin C on postoperative pain and morphine use after laparoscopic colectomy: A randomized controlled trial","volume":"2016","author":"Jeon","year":"2016","journal-title":"Pain Res. Manag."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/9\/2752\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:20:23Z","timestamp":1760196023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/9\/2752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,13]]},"references-count":65,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9]]}},"alternative-id":["ijms19092752"],"URL":"https:\/\/doi.org\/10.3390\/ijms19092752","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,13]]}}}